Publications by authors named "Nevin Murray"

Claim this Profile
S
Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219.
Barbara Melosky, Penelope Bradbury, Dongsheng Tu, Marie Florescu, Anthony Reiman, Nevin Murray

Lung Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of foretinib plus erlotinib in patients with previously treated advanced non-small cell lung cancer: Canadian cancer trials group IND.196.
Natasha B Leighl, Ming-Sound Tsao, Geoffrey Liu, Dongsheng Tu, Cheryl Ho, Nevin Murray

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer.
W James Morris, Scott Tyldesley, Sree Rodda, Ross Halperin, Howard Pai, Nevin Murray

Int J Radiat Oncol Biol Phys· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer.
Sree Rodda, Scott Tyldesley, W James Morris, Mira Keyes, Ross Halperin, Nevin Murray

Int J Radiat Oncol Biol Phys· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of PF-03446962 in Patients with Advanced Malignant Pleural Mesothelioma. CCTG Trial IND.207.
Paul Wheatley-Price, Quincy Chu, Maria Bonomi, Jean Seely, Ashish Gupta, Nevin Murray

J Thorac Oncol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan Canadian Rash Trial: A Randomized Phase III Trial Evaluating the Impact of a Prophylactic Skin Treatment Regimen on Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced Skin Toxicities in Patients With Metastatic Lung Cancer.
Barbara Melosky, Helen Anderson, Ronald L Burkes, Quincy Chu, Desiree Hao, Nevin Murray

J Clin Oncol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contrasting Management of Small Cell Lung Cancer and Non-Small Cell Lung Cancer: Emerging Data for Low-Dose Computed Tomography Screening.
Nevin Murray, Stephen Lam

J Thorac Oncol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Influence of the Evolution of First-Line Chemotherapy on Steadily Improving Survival in Advanced Non-Small-Cell Lung Cancer Clinical Trials.
Krista L Noonan, Cheryl Ho, Janessa Laskin, Nevin Murray

J Thorac Oncol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of GW786034 (pazopanib) with or without bicalutamide in patients with castration-resistant prostate cancer.
Srikala S Sridhar, Anthony M Joshua, Richard Gregg, Christopher M Booth, Nevin Murray

Clin Genitourin Cancer· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with abiraterone acetate in metastatic castration-resistant prostate cancer patients who have poor performance status.
Arun A Azad, Bernhard J Eigl, Raya Leibowitz-Amit, Renee Lester, Christian Kollmannsberger, Nevin Murray

Eur Urol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The challenge of using biomarkers and molecularly targeted drugs to improve cure rate in early stage non-small cell lung cancer.
Nevin Murray

J Thorac Dis· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of enzalutamide following abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer patients.
Arun A Azad, Bernhard J Eigl, R Nevin Murray, Christian Kollmannsberger, Kim N Chi

Eur Urol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Referral patterns in advanced non-small cell lung cancer: impact on delivery of treatment and survival in a contemporary population based cohort.
Krista Noonan, King Mong Tong, Janessa Laskin, Barbara Melosky, Sophie Sun, Nevin Murray

Lung Cancer· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective, Canadian multi-center study examining the impact of prior response to abiraterone acetate on efficacy of docetaxel in metastatic castration-resistant prostate cancer.
Arun A Azad, Raya Leibowitz-Amit, Bernhard J Eigl, Renee Lester, J Connor Wells, R Nevin Murray

Prostate· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of second-line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first-line cediranib.
Suzanne Richter, Jo-An Seah, Gregory R Pond, Hui K Gan, Mary J Mackenzie, Nevin Murray

Can Urol Assoc J· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Less toxic chemotherapy improves uptake of all lines of chemotherapy in advanced non-small-cell lung cancer: a 10-year retrospective population-based review.
Cheryl Ho, Katherine Ramsden, Yongliang Zhai, Nevin Murray, Sophie Sun

J Thorac Oncol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reality check for pemetrexed and maintenance therapy in advanced non-small-cell lung cancer.
Nevin Murray

J Clin Oncol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A population-based review of the feasibility of platinum-based combination chemotherapy after tyrosine kinase inhibition in EGFR mutation positive non-small cell lung cancer patients with advanced disease.
Caroline Mariano, Ian Bosdet, Aly Karsan, Diana Ionescu, Nevin Murray

Lung Cancer· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three primary testicular tumours: Trials and tribulations of testicular preservation.
Connor M Forbes, Charles Metcalfe, Nevin Murray, Peter C Black

Can Urol Assoc J· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of cediranib (AZD 2171) in treatment naive patients with progressive unresectable recurrent or metastatic renal cell carcinoma. A trial of the PMH phase 2 consortium.
Srikala S Sridhar, Mary J Mackenzie, Sebastien J Hotte, Som D Mukherjee, Ian F Tannock, Nevin Murray

Invest New Drugs· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Xin Dong, Dong Lin, Chris Low, Emily A Vucic, John C English, Nevin Murray

J Thorac Oncol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymoma: a population-based study of the management and outcomes for the province of British Columbia.
Caroline Mariano, Diana N Ionescu, Winson Y Cheung, Rola H Ali, Janessa Laskin, Nevin Murray

J Thorac Oncol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development.
William W Lockwood, Ian M Wilson, Bradley P Coe, Raj Chari, Larissa A Pikor, Nevin Murray

PLoS One· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
Shalini K Vinod, Elaine Wai, Cheryl Alexander, Scott Tyldesley, Nevin Murray

J Thorac Oncol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II pharmacodynamic study of preoperative figitumumab in patients with localized prostate cancer.
Kim N Chi, Martin E Gleave, Ladan Fazli, S Larry Goldenberg, Alan So, Nevin Murray

Clin Cancer Res· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis